None listed
Conditions
Interventions
Intervention1: From first to fourth week at least two sessions per week (45 mins/session).
The instructor will maintain an attendance register.
From fifth to 12th week At least two sessions per week (
Sponsors
UK DfID UK MRC and the NIHR AND Wellcome Trust Joint Global Health Trials
Eligibility
Inclusion criteria
Inclusion criteria: Aged 18-74 years. At high-risk of T2DM (fasting plasma glucose level from 100 to 125 mg/dL). Safe to participate in physical activities (assessed using the Physical Activity Readiness Questionnaire). Willing and able to attend the intervention/control sessions on their own. Able to provide written informed consent.
Exclusion criteria
Exclusion criteria: Pregnant women. Those with any serious or uncontrolled medical condition (e.g., cancer). Those who regularly practice yoga i.e., >= 150 minutes/week. Those currently receiving (or has plans to receive during the study period) any related non-pharmaceutical/pharmaceutical intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standard deviation (SD) of the outcome measure (i.e., difference in mean change (from the baseline to 6-month) in fasting plasma glucose level between the two treatment arms), which will be used to calculate sample size of the future RCT; reported.Timepoint: Baseline and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of people screened for eligibility, Number of participants followed-up at 6-month; Number of yoga sessions attended out of the total number of session; Time needed to collect and analyse data and socio-demographic information, medical history, medications, family history of diabetes, biochemical parameters, physiological parameters, anthropometric parameters, lifestyle factors, EQ-5D, depression, DASS-21, yoga practice, and self-efficacy assessment.Timepoint: Baseline and 6 months | — |
Countries
India
Contacts
Public ContactPallavi Mishra
Centre for Chronic Disease Control
Outcome results
None listed